Skip to main content
. 2021 Oct 28;1:142–149. doi: 10.1016/j.ijregi.2021.10.007

Table 3.

Susceptibilities and resistance profiles of uropathogens

Antibiotic Pattern Klebsiella spp. (50) E. coli (28) Citrobacter spp. (6) Proteus spp. (4) Pseudomonas spp. (2) Total No. (90)
AMP S (%) 6 (12) 4(14.3) 0(0) 0(0) 0(0) 10 (11.1)
R (%) 44(88) 24(85.7) 6(100) 4(100) 2(100) 80(88.9)
AMC S (%) 38(76) 22(78.6) 4(66.7) 4(100) 2(100) 70(77.8)
R (%) 12(24) 6 (21.4) 2(33.3) 0(0) 0(0)) 20(22.2)
CTX S (%) 36(72) 20(71.4) 4(66.7) 4(100) 2(100) 66(73.3)
R (%) 14(28) 8(28.6) 2(33.3) 0(0) 0(0) 24(26.7)
CTR S (%) 30(60) 18(64.3) 4(66.7) 4(100) 2(100) 38(42.2)
R (%) 20(40) 10(35.7) 2(33.3) 0(0) 0(0) 32(35.6)
CIP S (%) 38(76) 22(78.6) 6(100) 4(100) 2(100) 72(80)
R (%) 12(24) 6(21.4) 0(0) 0(0) 0(0) 18(20)
GEN S (%) 44(88) 24(85.7) 6(100) 4(100) 2(100) 80(88.9)
R (%) 6(12) 4(14.3) 0(0) 0(0) 0(0) 10(11.1)
NAL S (%) 26(52) 14(50) 4(66.7) 0(0) 0(0) 44(48.9)
R (%) 24(48) 14(50) 2(33.3) 4(100) 2(100) 46(51.1)
TRIM S (%) 26(52) 16(57.1) 4(66.7) 4(100) 2(100) 52(57.8)
R (%) 24(48) 12(42.8) 2(33.3) 0(0) 0(0) 38(42.2)

Key: AMP: ampicillin, AMC: amoxicillin-clavulanate, CTX: cefotaxime, CTR: ceftriazone, CIP: ciprofloxacin, GEN: gentamicin, NAL: nalidixic acid, TRIM: trimethoprim-sulfamethoxazole